Zomedica Pharmaceuticals Corp.
(TSX Venture Exchange : ZOM)

( )
ZOM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.10%129.670.7%$917.03m
PFEPfizer Inc.
-0.87%36.510.9%$717.72m
MRKMerck & Co., Inc.
0.59%82.510.7%$595.56m
ABBVAbbVie, Inc.
1.45%71.602.3%$552.44m
BMYBristol-Myers Squibb Company
0.55%49.741.4%$445.88m
LLYEli Lilly and Company
0.91%111.131.0%$325.26m
AZNAstraZeneca PLC Sponsored ADR
1.48%43.141.2%$143.14m
NVSNovartis AG Sponsored ADR
0.46%86.540.2%$132.47m
GSKGlaxoSmithKline plc Sponsored ADR
1.21%41.090.3%$82.16m
NVONovo Nordisk A/S Sponsored ADR Class B
3.01%50.970.1%$69.36m
SNYSanofi Sponsored ADR
1.61%44.300.2%$54.12m
LCILannett Company, Inc.
2.38%13.7635.6%$51.84m
AKTXAkari Therapeutics Plc Sponsored ADR
1.52%2.011.6%$2.23m
EPIXESSA Pharma Inc
-1.67%2.950.1%$0.18m

Company Profile

Zomedica Pharmaceuticals Corp. engages in the discovery, development and commercialization of pharmaceuticals for the companion pet. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.